Chemed Corp (NYSE:CHE)
$ 511.13 +8.12 (+1.61%) Market Cap: 6.78 Bil Enterprise Value: 7.00 Bil PE Ratio: 27.85 PB Ratio: 8.00 GF Score: 87/100

Chemed Corp at Bank of America Global Healthcare Conference Transcript

May 12, 2026 / 10:00 PM GMT
Release Date Price: $419.65 (-0.42%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

CHE.N - Chemed Corp
Chemed Corp at Bank of America Global Healthcare Conference
May 12, 2026 / 10:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
America Healthcare Conference. And my name is Joanna Gajwuk. I cover healthcare providers at Bank of America.

And now this session we have planned is with Kemet.

It's a very interesting company because it's partially healthcare. On healthcare. So we try to hit on these other topics as well. And today with us, we have the entire team.

So we have Kevin McNamara, who's the CEO. We have Mike Ritzmann, who's the CFO. And so we are looking at Joel Raley, who's the CEO of Vita. So we're going to talk about Vita first, put you on the spot. But then I want to touch base on the other business as well, because there are a lot of questions still floating around that business.

But I guess in, when it
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot